Evidence that “spike protein” does indeed play a major role in hypercoagulability seen in COVID-19 patients.
COVID-19 mRNA vaccines give instructions for our cells to make a piece of what is called the “spike protein.”
The S1 protein of SARS-CoV-2 crosses the blood–brain barrier.
COVID-19 mRNA vaccines give instructions for our cells to make a harmless(???!!!) piece of what is called the “spike protein.” The spike protein is found on the surface of the virus that causes COVID-19.
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/mrna.html
A denser fibrin clot formed in the presence of spike protein.
In this laboratory analysis, we provide evidence that spike protein does indeed play a major role in hypercoagulability seen in COVID-19 patients.
It causes anomalous clotting in both purified fluorescent fibrinogen and in PPP, where the nature of the clots were shown to be amyloid.
An interesting observation was that these dense deposits were noted both in smears exposed to spike protein, and when thrombin was added.
https://www.medrxiv.org/content/10.1101/2021.03.05.21252960v1.full
The S1 protein of SARS-CoV-2 crosses the blood–brain barrier in mice
https://www.nature.com/articles/s41593-020-00771-8
Blood-brain barrier function is negatively affected by SARS-CoV-2 spike protein subunits.
https://www.sciencedirect.com/science/article/pii/S096999612030406X